Earnings Feed
Start Free
Horizon Pharma plc·4

May 4, 6:03 PM ET

Horizon Pharma plc 4

4 · Horizon Pharma plc · Filed May 4, 2017

Insider Transaction Report

Form 4
Period: 2017-05-03
Horizon Pharma plcHZNP
Nohria Virinder
Director
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2017-05-03+13,953→ 19,211 total(indirect: By Trust)
  • Exercise/Conversion

    Restricted Stock Units

    2017-05-03−13,953→ 0 total
    → Ordinary shares (13,953 underlying)
  • Award

    Stock Option (Right to Buy)

    2017-05-03+31,153→ 31,153 total
    Exercise: $15.12Exp: 2027-05-02→ Ordinary shares (31,153 underlying)
  • Award

    Restricted Stock Units

    2017-05-03+14,054→ 14,054 total
    From: 2018-05-03→ Ordinary shares (14,054 underlying)
Holdings

  • Ordinary Shares

    189,836
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
  • [F2]On May 3, 2016, the reporting person was granted 13,953 restricted stock units, vesting in full on the first anniversary of the grant date.
  • [F3]The option vests in 12 equal monthly installments from the date of grant.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION